{"id":35836,"date":"2025-10-06T10:02:48","date_gmt":"2025-10-06T08:02:48","guid":{"rendered":"https:\/\/ggba.swiss\/?p=35836"},"modified":"2025-10-06T10:02:50","modified_gmt":"2025-10-06T08:02:50","slug":"spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/","title":{"rendered":"Spineart raises CHF 25 million to accelerate global expansion and innovation"},"content":{"rendered":"\n<p>Founded in Geneva, <a href=\"https:\/\/www.spineart.com\/\">Spineart<\/a> has become one of Switzerland\u2019s leading medtech innovators, combining design excellence with advanced digital and robotic technologies. The company is known for its BAGUERA\u00ae C cervical disc, a next-generation prosthesis designed to preserve motion and reduce complications in patients with degenerative cervical disc disorders. Following the completion of its FDA Investigational Device Exemption (IDE) studies, Spineart is now pursuing regulatory approvals in the United States.<\/p>\n\n\n\n<p>Spineart\u2019s growth strategy is built around a portfolio of high-precision implants, navigation systems, and robotic technologies. The company recently inaugurated a new 43,000-square-foot manufacturing facility in Reignier, France, and opened an R&amp;D and Training Center for Enabling Technologies in Dallas, Texas, to support its growing network of surgeons and healthcare partners.<\/p>\n\n\n\n<p>With over 360 employees worldwide, Spineart expects to achieve revenues of approximately EUR 140 million in 2025, marking five consecutive years of double-digit growth. The company\u2019s continued expansion across Europe and the U.S. underscores its ambition to become a global leader in spinal surgery innovation.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Shaping the future of spinal surgery<\/h4>\n\n\n\n<p>\u201cThis investment represents a major milestone in Spineart\u2019s profitable growth journey,\u201d said CEO J\u00e9r\u00f4me Trividic. \u201cWith the continued support of Gimv and EGSB, we are well-positioned to scale globally, deliver innovative, differentiated technologies, and reinforce our commitment to surgical excellence and improved patient outcomes.\u201d<\/p>\n\n\n\n<p><a href=\"https:\/\/www.gimv.com\/\">Gimv<\/a> and <a href=\"https:\/\/www.egs-beteiligungen.ch\/\">EGSB<\/a> emphasized their confidence in Spineart\u2019s potential to shape the future of spinal surgery. \u201cOur sustained commitment to Spineart reflects our strong belief in the company\u2019s innovation capabilities and international growth,\u201d said Gimv\u2019s healthcare partners Bart Diels and Gautier Lefebvre.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGS Beteiligungen (EGSB) to fuel its next phase of growth and global expansion.<\/p>\n","protected":false},"author":6,"featured_media":35837,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[894,890,963,926,886,935],"class_list":["post-35836","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-financing","tag-healthcare","tag-medical-devices","tag-medtech","tag-rd","tag-translational-medicine"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spineart raises CHF 25 million to accelerate global expansion<\/title>\n<meta name=\"description\" content=\"Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGSB.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spineart raises CHF 25 million to accelerate global expansion\" \/>\n<meta property=\"og:description\" content=\"Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGSB.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-06T08:02:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-06T08:02:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Spineart raises CHF 25 million to accelerate global expansion and innovation\",\"datePublished\":\"2025-10-06T08:02:48+00:00\",\"dateModified\":\"2025-10-06T08:02:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/\"},\"wordCount\":276,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\",\"keywords\":[\"Financing\",\"Healthcare\",\"Medical Devices\",\"Medtech\",\"R&amp;D\",\"Translational Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/\",\"url\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/\",\"name\":\"Spineart raises CHF 25 million to accelerate global expansion\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\",\"datePublished\":\"2025-10-06T08:02:48+00:00\",\"dateModified\":\"2025-10-06T08:02:50+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGSB.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Spineart develops next-generation spinal implants designed to make surgery safer, more efficient, and more precise. | \u00a9 Spineart\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spineart raises CHF 25 million to accelerate global expansion and innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spineart raises CHF 25 million to accelerate global expansion","description":"Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGSB.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Spineart raises CHF 25 million to accelerate global expansion","og_description":"Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGSB.","og_url":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-10-06T08:02:48+00:00","article_modified_time":"2025-10-06T08:02:50+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Spineart raises CHF 25 million to accelerate global expansion and innovation","datePublished":"2025-10-06T08:02:48+00:00","dateModified":"2025-10-06T08:02:50+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/"},"wordCount":276,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","keywords":["Financing","Healthcare","Medical Devices","Medtech","R&amp;D","Translational Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/","url":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/","name":"Spineart raises CHF 25 million to accelerate global expansion","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","datePublished":"2025-10-06T08:02:48+00:00","dateModified":"2025-10-06T08:02:50+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGSB.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/Spineart-impant-1180x811-1.jpg","width":1180,"height":811,"caption":"Spineart develops next-generation spinal implants designed to make surgery safer, more efficient, and more precise. | \u00a9 Spineart"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/spineart-raises-chf-25-million-to-accelerate-global-expansion-and-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Spineart raises CHF 25 million to accelerate global expansion and innovation"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=35836"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35836\/revisions"}],"predecessor-version":[{"id":35840,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35836\/revisions\/35840"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/35837"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=35836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=35836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=35836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}